Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex
Hui-Hua Li, … , Da-Zhi Wang, Cam Patterson
Hui-Hua Li, … , Da-Zhi Wang, Cam Patterson
Published October 15, 2004
Citation Information: J Clin Invest. 2004;114(8):1058-1071. https://doi.org/10.1172/JCI22220.
View: Text | PDF
Article Cardiology

Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex

  • Text
  • PDF
Abstract

Calcineurin, which binds to the Z-disc in cardiomyocytes via α-actinin, promotes cardiac hypertrophy in response to numerous pathologic stimuli. However, the endogenous mechanisms regulating calcineurin activity in cardiac muscle are not well understood. We demonstrate that a muscle-specific F-box protein called atrogin-1, or muscle atrophy F-box, directly interacts with calcineurin A and α-actinin-2 at the Z-disc of cardiomyocytes. Atrogin-1 associates with Skp1, Cul1, and Roc1 to assemble an SCFatrogin-1 complex with ubiquitin ligase activity. Expression of atrogin-1 decreases levels of calcineurin A and promotes its ubiquitination. Moreover, atrogin-1 attenuates agonist-induced calcineurin activity and represses calcineurin-dependent transactivation and NFATc4 translocation. Conversely, downregulation of atrogin-1 using adenoviral small interfering RNA (siRNA) expression enhances agonist-induced calcineurin activity and cardiomyocyte hypertrophy. Consistent with these cellular observations, overexpression of atrogin-1 in hearts of transgenic mice reduces calcineurin protein levels and blunts cardiac hypertrophy after banding of the thoracic aorta. These studies indicate that the SCFatrogin-1 ubiquitin ligase complex interacts with and represses calcineurin by targeting calcineurin for ubiquitin-mediated proteolysis, leading to inhibition of cardiac hypertrophy in response to pathologic stimuli.

Authors

Hui-Hua Li, Vishram Kedar, Chunlian Zhang, Holly McDonough, Ranjana Arya, Da-Zhi Wang, Cam Patterson

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 Total
Citations: 3 2 4 6 7 13 8 9 4 13 6 18 7 12 22 12 13 14 10 4 2 1 190
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (190)

Title and authors Publication Year
Ubiquitination in diabetes and its complications: A perspective from bibliometrics
Xiong LY, Zhao W, Hu FQ, Zhou XM, Zheng YJ
World Journal of Diabetes 2025
Thymoquinone mitigates cardiac hypertrophy by activating adaptive autophagy via the PPAR-γ/14-3-3γ pathway
Qiu RB, Zhao ST, Xu ZQ, Hu LJ, Zeng RY, Qiu ZC, Peng HZ, Zhou LF, Cao YP, Wan L
International Journal of Molecular Medicine 2025
Calpain inhibition in a transgenic model of calpastatin overexpression facilitates reversal of myocardial hypertrophy
Sachse G, Tennigkeit J, Pagonas N, Hillmeister P, Buschmann I, Czolbe M, Nordbeck P, Schmitt J, Patschan D, Ritter O
ESC Heart Failure 2025
Post-translational modifications in diabetic cardiomyopathy.
Li Z, Chen J, Huang H, Zhan Q, Wang F, Chen Z, Lu X, Sun G
Journal of Cellular and Molecular Medicine 2024
Atrogin-1 promotes muscle homeostasis by regulating levels of endoplasmic reticulum chaperone BiP.
Ruparelia AA, Montandon M, Merriner J, Huang C, Wong SFL, Sonntag C, Hardee JP, Lynch GS, Miles LB, Siegel A, Hall TE, Schittenhelm RB, Currie PD
JCI Insight 2024
Identification of hypertrophy-modulating Cullin-RING ubiquitin ligases in primary cardiomyocytes
Fischer M, Jakab M, Hirt MN, Werner TR, Engelhardt S, Sarikas A
Frontiers in physiology 2023
Pathological implications of cellular stress in cardiovascular diseases.
Ulaganathan T, Perales S, Mani S, Baskhairoun BA, Rajasingh J
The International Journal of Biochemistry & Cell Biology 2023
Promotive Effect of FBXO32 on the Odontoblastic Differentiation of Human Dental Pulp Stem Cells
Xu K, Liu Q, Huang W, Chu Y, Fan W, Liu J, He Y, Huang F
International journal of molecular sciences 2023
Effect of optimized new Shengmai powder on exercise tolerance in rats with heart failure by regulating the ubiquitin-proteasome signaling pathway
Wang S, Wang L, Gu S, Han Y, Li L, Jia Z, Gao N, Liu Y, Lin S, Hou Y, Wang X, Mao J
Frontiers in Cardiovascular Medicine 2023
Roles of Cullin-RING Ubiquitin Ligases in Cardiovascular Diseases
S Diaz, K Wang, B Sjögren, X Liu
Biomolecules 2022
Plant Bioactives in the Treatment of Inflammation of Skeletal Muscles: A Molecular Perspective.
Karati D, Varghese R, Mahadik KR, Sharma R, Kumar D
Evidence-based complementary and alternative medicine : eCAM 2022
Hyperhomocysteinemia Promotes Cardiac Hypertrophy in Hypertension
Deng Y, Li Z, An X, Fan R, Wang Y, Li J, Yang X, Liao J, Xia Y
Oxidative medicine and cellular longevity 2022
Lactacystin-induced kidney fibrosis: Protection by melatonin and captopril
Repova K, Stanko P, Baka T, Krajcirovicova K, Aziriova S, Hrenak J, Barta A, Zorad S, Reiter RJ, Adamcova M, Simko F
Frontiers in pharmacology 2022
Calcineurin Signalling in Astrocytes: From Pathology to Physiology and Control of Neuronal Functions.
Lim D, Tapella L, Dematteis G, Talmon M, Genazzani AA
Neurochemical Research 2022
Effects of an exogenous ketone ester using multi-omics in skeletal muscle of aging C57BL/6J male mice
Roberts BM, Deemer SE, Smith DL Jr, Mobley JA, Musi N, Plaisance EP
Frontiers in Nutrition 2022
SOCS3 Negatively Regulates Cardiac Hypertrophy via Targeting GRP78-Mediated ER Stress During Pressure Overload
S Liu, WC Sun, YL Zhang, QY Lin, JW Liao, GR Song, XL Ma, HH Li, B Zhang
Frontiers in Cell and Developmental Biology 2021
VEGF‐C/VEGFR‐3 axis protects against pressure‐overload induced cardiac dysfunction through regulation of lymphangiogenesis
QY Lin, YL Zhang, J Bai, JQ Liu, HH Li
Clinical and Translational Medicine 2021
Pathophysiological mechanisms leading to muscle loss in chronic kidney disease
XH Wang, WE Mitch, SR Price
Nature Reviews Nephrology 2021
The Role of HECT-Type E3 Ligase in the Development of Cardiac Disease
J Goto, Y Otaki, T Watanabe, M Watanabe
International journal of molecular sciences 2021
Mutation in FBXO32 causes dilated cardiomyopathy through up-regulation of ER-stress mediated apoptosis
N Al-Yacoub, D Colak, SA Mahmoud, M Hammonds, K Muhammed, O Al-Harazi, AM Assiri, J Al-Buraiki, W Al-Habeeb, C Poizat
2021
ACTN3 genotype influences skeletal muscle mass regulation and response to dexamethasone
JT Seto, KN Roeszler, LR Meehan, HD Wood, C Tiong, L Bek, SF Lee, M Shah, KG Quinlan, P Gregorevic, PJ Houweling, KN North
Science Advances 2021
Thymoquinone ameliorates pressure overload-induced cardiac hypertrophy by activating the AMPK signalling pathway.
Chen H, Zhuo C, Zu A, Yuan S, Zhang H, Zhao J, Zheng L
Journal of Cellular and Molecular Medicine 2021
The ubiquitin–proteasome system in regulation of the skeletal muscle homeostasis and atrophy: from basic science to disorders
Y Kitajima, K Yoshioka, N Suzuki
The Journal of Physiological Sciences 2020
Deficiency of the Immunoproteasome LMP10 Subunit Attenuates Angiotensin II-Induced Cardiac Hypertrophic Remodeling via Autophagic Degradation of gp130 and IGF1R
W Yan, ZC Dong, JJ Wang, YL Zhang, HX Wang, B Zhang, HH Li
Frontiers in physiology 2020
Maxacalcitol (22-Oxacalcitriol (OCT)) Retards Progression of Left Ventricular Hypertrophy with Renal Dysfunction Through Inhibition of Calcineurin-NFAT Activity
K Inoue, I Matsui, T Hamano, K Okuda, Y Tsukamoto, A Matsumoto, K Shimada, S Yasuda, Y Katsuma, Y Takabatake, M Tanaka, N Tanaka, T Mano, T Minamino, Y Sakata, Y Isaka
Cardiovascular Drugs and Therapy 2020
The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease
J Blondelle, A Biju, S Lange
International journal of molecular sciences 2020
The Calcineurin-TFEB-p62 Pathway Mediates the Activation of Cardiac Macroautophagy by Proteasomal Malfunction
B Pan, J Li, N Parajuli, Z Tian, P Wu, MT Lewno, J Zou, W Wang, L Bedford, RJ Mayer, J Fang, J Liu, T Cui, H Su, X Wang
Circulation research 2020
Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside
N Kaur, R Raja, A Ruiz-Velasco, W Liu
Frontiers in Cardiovascular Medicine 2020
Detecting the Effects of the Glucocorticoid Dexamethasone on Primary Human Skeletal Muscle Cells—Differences to the Murine Cell Line
EK Langendorf, PM Rommens, P Drees, SG Mattyasovszky, U Ritz
International journal of molecular sciences 2020
The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor
HL Bi, XL Zhang, YL Zhang, X Xie, YL Xia, J Du, HH Li
Science Advances 2020
Calpain activation mediates microgravity-induced myocardial abnormalities in mice via p38 and ERK1/2 MAPK pathways
L Liang, H Li, T Cao, L Qu, L Zhang, GC Fan, PA Greer, J Li, DL Jones, T Peng
The Journal of biological chemistry 2020
Assembly and Maintenance of Sarcomere Thin Filaments and Associated Diseases
K Prill, JF Dawson
International journal of molecular sciences 2020
Ubiquitin‐specific protease 19 blunts pathological cardiac hypertrophy via inhibition of the TAK1‐dependent pathway
R Miao, Y Lu, X He, X Liu, Z Chen, J Wang
Journal of Cellular and Molecular Medicine 2020
Calcineurin Controls Expression of EAAT1/GLAST in Mouse and Human Cultured Astrocytes through Dynamic Regulation of Protein Synthesis and Degradation
G Dematteis, E Restelli, R Chiesa, E Aronica, AA Genazzani, D Lim, L Tapella
International journal of molecular sciences 2020
The regulatory roles of p53 in cardiovascular health and disease
H Men, H Cai, Q Cheng, W Zhou, X Wang, S Huang, Y Zheng, L Cai
Cellular and Molecular Life Sciences 2020
USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance
Yu Zhang, Rong-bei Liu, Qian Cao, Ke-qi Fan, Ling-jie Huang, Jian-shuai Yu, Zheng-jun Gao, Tao Huang, Jiang-yan Zhong, Xin-tao Mao, Fei Wang, Peng Xiao, Yuan Zhao, Xin-Hua Feng, Yiyuan Li, Jin Jin
Journal of Clinical Investigation 2019
Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212
M Sárközy, R Gáspár, Á Zvara, A Siska, B Kővári, G Szűcs, F Márványkövi, MG Kovács, P Diószegi, L Bodai, N Zsindely, M Pipicz, K Gömöri, K Kiss, P Bencsik, G Cserni, LG Puskás, I Földesi, T Thum, S Bátkai, T Csont
Scientific Reports 2019
The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation
X Xie, HL Bi, S Lai, YL Zhang, N Li, HJ Cao, L Han, HX Wang, HH Li
Science Advances 2019
Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers
Y Song, M Lin, Y Liu, ZW Wang, X Zhu
Stem Cell Research & Therapy 2019
Mitochondrial dysregulation and muscle disuse atrophy
LL Ji, D Yeo
F1000Research 2019
A Discovery of a Genetic Mutation Causing Reduction of Atrogin-1 Expression in Broiler Chicken Muscle.
Li J, Hu Y, Li L, Wang Y, Li Q, Feng C, Lan H, Gu X, Zhao Y, Larsson M, Hu X, Li N
Frontiers in Genetics 2019
The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
Spänig S, Kellermann K, Dieterlen MT, Noack T, Lehmann S, Borger MA, Garbade J, Barac YD, Emrich F
International journal of molecular sciences 2019
Cellular mechanism of immobilization-induced muscle atrophy: A mini review
Ji LL, Yeo D
2019
Proteasome Biology and Therapeutics in Cardiac Diseases
SK Shukla, K Rafiq
Translational research : the journal of laboratory and clinical medicine 2018
Allopurinol partially prevents disuse muscle atrophy in mice and humans
B Ferrando, MC Gomez-Cabrera, A Salvador-Pascual, C Puchades, F Derbré, A Gratas-Delamarche, L Laparre, G Olaso-Gonzalez, M Cerda, E Viosca, A Alabajos, V Sebastiá, A Alberich-Bayarri, F García-Castro, J Viña
Scientific Reports 2018
Increasing Cardiomyocyte Atrogin-1 Reduces Aging-Associated Fibrosis and Regulates Remodeling in Vivo
R Mota, TL Parry, CC Yates, Z Qiang, SC Eaton, JM Mwiza, D Tulasi, JC Schisler, C Patterson, T Zaglia, M Sandri, MS Willis
The American Journal of Pathology 2018
Overexpression of the double homeodomain protein DUX4c interferes with myofibrillogenesis and induces clustering of myonuclei
C Vanderplanck, A Tassin, E Ansseau, S Charron, A Wauters, C Lancelot, K Vancutsem, D Laoudj-Chenivesse, A Belayew, F Coppée
Skeletal Muscle 2018
Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
C Chen, LX Zou, QY Lin, X Yan, HL Bi, X Xie, S Wang, QS Wang, YL Zhang, HH Li
Redox Biology 2018
CDC20 regulates cardiac hypertrophy via targeting LC3-dependent autophagy
YP Xie, S Lai, QY Lin, X Xie, JW Liao, HX Wang, C Tian, HH Li
Theranostics 2018
Ubiquitin and ubiquitin-like proteins in cardiac disease and protection
Li J, Johnson JA, Su H
Current drug targets 2018
Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
Yuan X, Zhang Z, Jiang K, Wang X, Li Y
Medical science monitor : international medical journal of experimental and clinical research 2018
EZH2 contributes to 5-FU resistance in gastric cancer by epigenetically suppressing FBXO32 expression.
Wang C, Li X, Zhang J, Ge Z, Chen H, Hu J
OncoTargets and therapy 2018
Proteasome dysfunction in cardiomyopathies: Proteasome dysfunction in cardiomyopathies
JE Gilda, AV Gomes
The Journal of Physiology 2017
CD38 promotes angiotensin II-induced cardiac hypertrophy
XH Guan, X Hong, N Zhao, XH Liu, YF Xiao, TT Chen, LB Deng, XL Wang, JB Wang, GJ Ji, M Fu, KY Deng, HB Xin
Journal of Cellular and Molecular Medicine 2017
E2/ER β Enhances Calcineurin Protein Degradation and PI3K/Akt/MDM2 Signal Transduction to Inhibit ISO-Induced Myocardial Cell Apoptosis
KH Lin, WW Kuo, M Shibu, CH Day, YL Hsieh, LC Chung, RJ Chen, SY Wen, V Viswanadha, CY Huang
International journal of molecular sciences 2017
Suppression of CLC-3 chloride channel reduces the aggressiveness of glioma through inhibiting nuclear factor-κB pathway
B Wang, J Xie, HY He, EW Huang, QH Cao, L Luo, YS Liao, Y Guo
Oncotarget 2017
Acquired platinum resistance involves epithelial-to-mesenchymal transition through ubiquitin ligase FBXO32 dysregulation
Nobuyuki Tanaka, Takeo Kosaka, Yasumasa Miyazaki, Shuji Mikami, Naoya Niwa, Yutaro Otsuka, Yoji Andrew Minamishima, Ryuichi Mizuno, Eiji Kikuchi, Akira Miyajima, Hisataka Sabe, Yasunori Okada, Per Uhlén, Makoto Suematsu, Mototsugu Oya
JCI Insight 2016
Smad2/3 Proteins Are Required for Immobilization-induced Skeletal Muscle Atrophy
T Tando, A Hirayama, M Furukawa, Y Sato, T Kobayashi, A Funayama, A Kanaji, W Hao, R Watanabe, M Morita, T Oike, K Miyamoto, T Soga, M Nomura, A Yoshimura, M Tomita, M Matsumoto, M Nakamura, Y Toyama, T Miyamoto
The Journal of biological chemistry 2016
Regulation of myoglobin in hypertrophied rat cardiomyocytes in experimental pulmonary hypertension
EL Peters, C Offringa, D Kos, WJ van der Laarse, RT Jaspers
Pflügers Archiv - European Journal of Physiology 2016
Recent advances in SCF ubiquitin ligase complex: Clinical implications
N Zheng, Q Zhou, Z Wang, W Wei
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2016
Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein
L Wang, TP Zhang, Y Zhang, HL Bi, XM Guan, HX Wang, X Wang, J Du, YL Xia, HH Li
Scientific Reports 2016
A substitution mutation in cardiac ubiquitin ligase, FBXO32, is associated with an autosomal recessive form of dilated cardiomyopathy
ZN Al-Hassnan, ZM Shinwari, SM Wakil, S Tulbah, S Mohammed, Z Rahbeeni, M Alghamdi, M Rababh, D Colak, N Kaya, M Al-Fayyadh, J Alburaiki
BMC Medical Genetics 2016
MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo
KM Wadosky, JM Berthiaume, W Tang, M Zungu, MA Portman, AM Gerdes, MS Willis
Journal of Molecular Endocrinology 2016
Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure
W Deng, AR Ednie, J Qi, ES Bennett
Basic Research in Cardiology 2016
Identification of the Mtus1 Splice Variant as a Novel Inhibitory Factor Against Cardiac Hypertrophy
S Ito, M Asakura, Y Liao, KD Min, A Takahashi, K Shindo, S Yamazaki, O Tsukamoto, H Asanuma, M Mogi, M Horiuchi, Y Asano, S Sanada, T Minamino, S Takashima, N Mochizuki, M Kitakaze
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2016
Rare Copy Number Variants Identified Suggest the Regulating Pathways in Hypertension-Related Left Ventricular Hypertrophy
H Boon-Peng, JA Jusoh, CR Marshall, F Majid, N Danuri, F Basir, B Thiruvahindrapuram, SW Scherer, K Yusoff, R Morishita
PloS one 2016
BMP TYPE I RECEPTOR ALK2 IS REQUIRED FOR ANGIOTENSIN II-INDUCED CARDIAC HYPERTROPHY
M Shahid, E Spagnolli, L Ernande, R Thoonen, SA Kolodziej, PA Leyton, J Cheng, RE Tainsh, C Mayeur, DK Rhee, MX Wu, M Scherrer-Crosbie, ES Buys, WM Zapol, KD Bloch, DB Bloch
American journal of physiology. Heart and circulatory physiology 2016
Atrogin-1 Deficiency Leads to Myopathy and Heart Failure in Zebrafish
A Bühler, M Kustermann, T Bummer, W Rottbauer, M Sandri, S Just
International journal of molecular sciences 2016
Characterization of SCF-Complex during Bovine Preimplantation Development
V Benesova, V Kinterova, J Kanka, T Toralova, SM Srinivasula
PloS one 2016
Ongoing controversies surrounding cardiac remodeling: is it black and white—or rather fifty shades of gray?
S Spaich
Frontiers in physiology 2015
Inflammation induced loss of skeletal muscle
P Londhe, DC Guttridge
Bone 2015
Circulating E3 ligases are novel and sensitive biomarkers for diagnosis of acute myocardial infarction
QY Han, HX Wang, XH Liu, CX Guo, Q Hua, XH Yu, N Li, YZ Yang, J Du, YL Xia, HH Li
Clinical Science 2015
Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model
K Li, S Cui, XT Song, LJ Meng, S Lv, C Ding
Drug design, development and therapy 2015
The administration of Fructus Schisandrae attenuates dexamethasone-induced muscle atrophy in mice
J Kim, SK Ku, M Han, K Kim, S Kim, GY Kim, H Hwang, B Kim, C Kim, Y Choi
International journal of molecular medicine 2015
PGC-1  overexpression by in vivo transfection attenuates mitochondrial deterioration of skeletal muscle caused by immobilization
C Kang, CA Goodman, TA Hornberger, LL Ji
The FASEB Journal 2015
Ablation of Atrogin-1 impairs autophagy causing cardiomyopathy and premature death
Tania Zaglia, Giulia Milan, Aaron Ruhs, Mauro Franzoso, enrico Bertaggia, Nicola Pianca, Andrea Carpi, Pierluigi Carullo, Paola Pesce, David Sacerdoti, Cristiano Sarais, Daniele Catalucci, Marcus Krueger, Marco Mongillo, Marco Sandri
Journal of Clinical Investigation 2014
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease
RL Neppl, DZ Wang
Genes & Diseases 2014
Targeting the Ubiquitin-Proteasome System in Heart Disease: The Basis for New Therapeutic Strategies
O Drews, H Taegtmeyer
Antioxidants & Redox Signaling 2014
Minireview: Hey U(PS): Metabolic and Proteolytic Homeostasis Linked via AMPK and the Ubiquitin Proteasome System
SM Ronnebaum, C Patterson, JC Schisler
Molecular Endocrinology 2014
Signaling pathways controlling skeletal muscle mass
MA Egerman, DJ Glass
Critical Reviews in Biochemistry and Molecular Biology 2014
Current understanding of sarcopenia: possible candidates modulating muscle mass
K Sakuma, W Aoi, A Yamaguchi
Pflügers Archiv - European Journal of Physiology 2014
Characterization of GLPG0492, a selective androgen receptor modulator, in a mouse model of hindlimb immobilization
R Blanqué, L Lepescheux, M Auberval, D Minet, D Merciris, C Cottereaux, P Clément-Lacroix, P Delerive, F Namour
BMC musculoskeletal disorders 2014
Deletion of atrophy enhancing genes fails to ameliorate the phenotype in a mouse model of spinal muscular atrophy
CC Iyer, VL McGovern, DO Wise, DJ Glass, AH Burghes
Neuromuscular Disorders 2014
MAFbx/Atrogin-1 is required for atrophic remodeling of the unloaded heart
KK Baskin, MR Rodriguez, S Kansara, W Chen, S Carranza, OH Frazier, DJ Glass, H Taegtmeyer
Journal of Molecular and Cellular Cardiology 2014
The role of ubiquitin ligases in cardiac disease
MS Willis, A Bevilacqua, T Pulinilkunnil, P Kienesberger, M Tannu, C Patterson
Journal of Molecular and Cellular Cardiology 2014
A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries
S Cui, JH Liu, XT Song, GL Ma, BJ Du, SZ Lv, LJ Meng, QS Gao, K Li
BioMed Research International 2014
The Intriguing Regulators of Muscle Mass in Sarcopenia and Muscular Dystrophy
K Sakuma, W Aoi, A Yamaguchi
Frontiers in aging neuroscience 2014
Calcineurin mediates synaptic scaling via synaptic trafficking of Ca2+-permeable AMPA receptors
S Kim, EB Ziff
PLoS Biology 2014
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
SC Bodine, LM Baehr
American journal of physiology. Endocrinology and metabolism 2014
c-Cbl Inhibition Improves Cardiac Function and Survival in Response to Myocardial Ischemia
K Rafiq, MA Kolpakov, R Seqqat, J Guo, X Guo, Z Qi, D Yu, B Mohapatra, N Zutshi, W An, H Band, A Sanjay, SR Houser, A Sabri
Circulation 2014
Muscle-Specific RING Finger 1 Negatively Regulates Pathological Cardiac Hypertrophy Through Downregulation of Calcineurin A
Y Maejima, S Usui, P Zhai, M Takamura, S Kaneko, D Zablocki, M Yokota, M Isobe, J Sadoshima
Circulation. Heart failure 2014
Androgenic and estrogenic regulation of Atrogin-1, MuRF1 and myostatin expression in different muscle types of male mice
HD Naeyer, S Lamon, AP Russell, I Everaert, AD Spaey, B Vanheel, Y Taes, W Derave
European Journal of Applied Physiology 2014
Effect of MGF E-peptide on anabolic and proteolytic signaling pathways in rat m. gastrocnemius medialis.
Mirzoev TM, Turtikova OV, Lomonosova YN, Nemirovskaya TL, Alekseev SM, Kovtun AL, Ushakov IB, Shenkman BS
Doklady Biochemistry and Biophysics 2014
Mechanical Unloading Activates FoxO3 to Trigger Bnip3‐Dependent Cardiomyocyte Atrophy
DJ Cao, N Jiang, A Blagg, JL Johnstone, R Gondalia, M Oh, X Luo, KC Yang, JM Shelton, BA Rothermel, TG Gillette, GW Dorn, JA Hill
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2013
Cellular and molecular mechanisms of muscle atrophy
P Bonaldo, M Sandri
Disease models & mechanisms 2013
Transcriptional effects of E3 ligase atrogin-1/MAFbx on apoptosis, hypertrophy and inflammation in neonatal rat cardiomyocytes
Y Zeng, HX Wang, SB Guo, H Yang, XJ Zeng, Q Fang, CS Tang, J Du, HH Li
PloS one 2013
Calcineurin: A poorly understood regulator of muscle mass
MB Hudson, SR Price
The International Journal of Biochemistry & Cell Biology 2013
Protein breakdown in muscle wasting: Role of autophagy-lysosome and ubiquitin-proteasome☆☆☆
M Sandri
The International Journal of Biochemistry & Cell Biology 2013
Breaking Down Protein Degradation Mechanisms In Cardiac Muscle: Therapeutic Outlooks For Disease
RC Lyon, S Lange, F Sheikh
Trends in Molecular Medicine 2013
miR-23a is decreased during muscle atrophy by a mechanism that includes calcineurin signaling and exosome-mediated export
MB Hudson, ME Woodworth-Hobbs, B Zheng, JA Rahnert, MA Blount, JL Gooch, CD Searles, SR Price
American journal of physiology. Cell physiology 2013
JNK modulates FOXO3a for the expression of the mitochondrial death and mitophagy marker BNIP3 in pathological hypertrophy and in heart failure
AH Chaanine, D Jeong, L Liang, ER Chemaly, K Fish, RE Gordon, RJ Hajjar
Cell Death and Disease 2012
Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
DF Dai, T Chen, SC Johnson, H Szeto, PS Rabinovitch
Antioxidants & Redox Signaling 2012
Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit
M Cheng, G Qin
Progress in molecular biology and translational science 2012
Distinct Cardiac Transcriptional Profiles Defining Pregnancy and Exercise
E Chung, J Heimiller, LA Leinwand
PloS one 2012
Ischemia/Reperfusion-Induced MKP-3 Impairs Endothelial NO Formation via Inactivation of ERK1/2 Pathway
D Yang, P Xie, Z Liu
PloS one 2012
An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of aging
D Wang, Y Wang, C Argyriou, A Carrière, D Malo, S Hekimi
PloS one 2012
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
A Ucar, SK Gupta, J Fiedler, E Erikci, M Kardasinski, S Batkai, S Dangwal, R Kumarswamy, C Bang, A Holzmann, J Remke, M Caprio, C Jentzsch, S Engelhardt, S Geisendorf, C Glas, TG Hofmann, M Nessling, K Richter, M Schiffer, L Carrier, LC Napp, J Bauersachs, K Chowdhury, T Thum
Nature Communications 2012
Human molecular genetic and functional studies identify TRIM63, encoding Muscle RING Finger Protein 1, as a novel gene for human hypertrophic cardiomyopathy
SN Chen, G Czernuszewicz, Y Tan, R Lombardi, J Jin, JT Willerson, AJ Marian
Circulation research 2012
Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics
SB Scruggs, NC Zong, D Wang, E Stefani, P Ping
American journal of physiology. Heart and circulatory physiology 2012
Cardiac and vascular atrogin-1 mRNA expression is not associated with dexamethasone efficacy in the monocrotaline model of pulmonary hypertension
ML Paffett, MM Channell, JS Naik, SN Lucas, MJ Campen
Cardiovascular Toxicology 2012
Obscurin and KCTD6 regulate cullin-dependent small ankyrin-1 (sAnk1.5) protein turnover
S Lange, S Perera, P Teh, J Chen, WP Tansey
Molecular biology of the cell 2012
Foxo/Atrogin induction in human and experimental myositis
Lee HK, Rocnik E, Fu Q, Kwon B, Zeng L, Walsh K, Querfurth H
Neurobiology of Disease 2012
The Ubiquitin Ligase MuRF1 Protects Against Cardiac Ischemia/Reperfusion Injury by Its Proteasome-Dependent Degradation of Phospho-c-Jun
HH Li, J Du, YN Fan, ML Zhang, DP Liu, L Li, P Lockyer, EY Kang, C Patterson, MS Willis
The American Journal of Pathology 2011
Myocardial AKT: the omnipresent nexus
MA Sussman, M Völkers, K Fischer, B Bailey, CT Cottage, S Din, N Gude, D Avitabile, R Alvarez, B Sundararaman, P Quijada, M Mason, MH Konstandin, A Malhowski, Z Cheng, M Khan, M McGregor
Physiological reviews 2011
Endogenous Muscle Atrophy F-Box Mediates Pressure Overload–Induced Cardiac Hypertrophy Through Regulation of Nuclear Factor-κB
S Usui, Y Maejima, J Pain, C Hong, J Cho, JY Park, D Zablocki, B Tian, DJ Glass, J Sadoshima
Circulation research 2011
Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks
SS Wing, SH Lecker, RT Jagoe
Critical Reviews in Clinical Laboratory Sciences 2011
Tearin' Up My Heart: Proteolysis in the Cardiac Sarcomere*
AL Portbury, MS Willis, C Patterson
The Journal of biological chemistry 2011
c-Cbl ubiquitin ligase regulates focal adhesion protein turnover and myofibril degeneration induced by neutrophil protease cathepsin G
K Rafiq, J Guo, L Vlasenko, X Guo, MA Kolpakov, A Sanjay, SR Houser, A Sabri
The Journal of biological chemistry 2011
Muscle-Specific RING Finger (MuRF) cDNAs in Atlantic Salmon (Salmo salar) and Their Role as Regulators of Muscle Protein Degradation
L Tacchi, R Bickerdike, CJ Secombes, SA Martin
Marine Biotechnology 2011
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
VC Foletta, LJ White, AE Larsen, B Léger, AP Russell
Pflügers Archiv - European Journal of Physiology 2011
Overexpression of nrdp1 in the heart exacerbates Doxorubicin-induced cardiac dysfunction in mice
Y Zhang, YM Kang, C Tian, Y Zeng, LX Jia, X Ma, J Du, HH Li
PloS one 2011
Taking pressure off the heart: the ins and outs of atrophic remodelling
KK Baskin, H Taegtmeyer
Cardiovascular Research 2011
The Sarcomeric Z-Disc and Z-Discopathies
R Knöll, B Buyandelger, M Lab
Journal of Biomedicine and Biotechnology 2011
Back to your heart: Ubiquitin proteasome system-regulated signal transduction
AL Portbury, SM Ronnebaum, M Zungu, C Patterson, MS Willis
Journal of Molecular and Cellular Cardiology 2011
Cardiac Z-disc Signaling Network*
D Frank, N Frey
The Journal of biological chemistry 2011
β-Adrenergic Receptor-PI3K Signaling Crosstalk in Mouse Heart: Elucidation of Immediate Downstream Signaling Cascades
W Zhang, N Yano, M Deng, Q Mao, SK Shaw, YT Tseng
PloS one 2011
Tear me down: Role of calpain in the development of cardiac ventricular hypertrophy
C Patterson, AL Portbury, JC Schisler, MS Willis
Circulation research 2011
Proteasome functional insufficiency in cardiac pathogenesis
X Wang, J Li, H Zheng, H Su, SR Powell
American journal of physiology. Heart and circulatory physiology 2011
Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle
ML Paffett, SN Lucas, MJ Campen
Vascular Pharmacology 2011
Mechanisms and management of doxorubicin cardiotoxicity
Y Shi, M Moon, S Dawood, B McManus, PP Liu
Herz 2011
An Expanded Role for AMP-Activated Protein Kinase: Regulator of Myocardial Protein Degradation
KK Baskin, H Taegtmeyer
Trends in Cardiovascular Medicine 2011
Perturbation of Cullin Deneddylation via Conditional Csn8 Ablation Impairs the Ubiquitin–Proteasome System and Causes Cardiomyocyte Necrosis and Dilated Cardiomyopathy in Mice
H Su, J Li, S Menon, J Liu, AR Kumarapeli, N Wei, X Wang
Circulation research 2011
AMP-Activated Protein Kinase Regulates E3 Ligases in Rodent Heart
KK Baskin, H Taegtmeyer
Circulation research 2011
Transcriptional mechanisms regulating skeletal muscle differentiation, growth and homeostasis
T Braun, M Gautel
Nature Reviews Molecular Cell Biology 2011
The FoxO Family in Cardiac Function and Dysfunction
SM Ronnebaum, C Patterson
Annual Review of Physiology 2010
Oxidative stress, molecular inflammation and sarcopenia
SJ Meng, LJ Yu
International journal of molecular sciences 2010
Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
V Moresi, AH Williams, E Meadows, JM Flynn, MJ Potthoff, J McAnally, JM Shelton, J Backs, WH Klein, JA Richardson, R Bassel-Duby, EN Olson
Cell 2010
The Functional Role of Calcineurin in Hypertrophy, Regeneration, and Disorders of Skeletal Muscle
K Sakuma, A Yamaguchi
Journal of Biomedicine and Biotechnology 2010
Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease
MS Willis, WH Townley-Tilson, EY Kang, JW Homeister, C Patterson
Circulation research 2010
Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer
JL Chou, HY Su, LY Chen, YP Liao, C Hartman-Frey, YH Lai, HW Yang, DE Deatherage, CT Kuo, YW Huang, PS Yan, SH Hsiao, CK Tai, HJ Lin, RV Davuluri, TK Chao, KP Nephew, TH Huang, HC Lai, MW Chan
Laboratory Investigation 2010
Cyclic GMP/PKG-dependent inhibition of TRPC6 channel activity and expression negatively regulates cardiomyocyte NFAT activation Novel mechanism of cardiac stress modulation by PDE5 inhibition
N Koitabashi, T Aiba, GG Hesketh, J Rowell, M Zhang, E Takimoto, GF Tomaselli, DA Kass
Journal of Molecular and Cellular Cardiology 2010
Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy
W Qin, J Pan, WA Bauman, CP Cardozo
BMC Genomics 2010
Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway
D Yang, J Liu, C Tian, Y Zeng, Y Zheng, Q Fang, H Li
Acta Pharmacologica Sinica 2010
Proteasome functional insufficiency activates the calcineurin–NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts
M Tang, J Li, W Huang, H Su, Q Liang, Z Tian, KM Horak, JD Molkentin, X Wang
Cardiovascular Research 2010
Skeletal Muscle Catabolism in TNBS-Induced Murine Colitis
F Puleo, K Meirelles, M Navaratnarajah, L Fitzpatrick, ML Shumate, RN Cooney, CH Lang
Metabolism: clinical and experimental 2010
NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression
Q Li, X Lin, X Yang, J Chang
American journal of physiology. Heart and circulatory physiology 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Proteasome inhibitors and cardiac cell growth
N Hedhli, C Depre
Cardiovascular Research 2009
FoxO transcription factors promote autophagy in cardiomyocytes
A Sengupta, JD Molkentin, KE Yutzey
The Journal of biological chemistry 2009
Statin-induced muscle damage and atrogin-1 induction is the result of a geranylgeranylation defect
P Cao, J Hanai, P Tanksale, S Imamura, VP Sukhatme, SH Lecker
The FASEB Journal 2009
Differential skeletal muscle gene expression after upper or lower motor neuron transection
RJ Zeman, J Zhao, Y Zhang, W Zhao, X Wen, Y Wu, J Pan, WA Bauman, C Cardozo
Pflügers Archiv - European Journal of Physiology 2009
Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo
J Lagirand-Cantaloube, K Cornille, A Csibi, S Batonnet-Pichon, MP Leibovitch, SA Leibovitch
PloS one 2009
Limb immobilization induces a coordinate down-regulation of mitochondrial and other metabolic pathways in men and women
A Abadi, EI Glover, RJ Isfort, S Raha, A Safdar, N Yasuda, JJ Kaczor, S Melov, A Hubbard, X Qu, SM Phillips, M Tarnopolsky
PloS one 2009
Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms
G Mearini, C Gedicke, S Schlossarek, CC Witt, E Kramer, P Cao, MD Gomes, SH Lecker, S Labeit, MS Willis, T Eschenhagen, L Carrier
Cardiovascular Research 2009
Seek and destroy: The ubiquitin-proteasome system in cardiac disease
JE Rodríoguez, JC Schisler, C Patterson, MS Willis
Current Hypertension Reports 2009
C terminus of Hsc70-interacting protein promotes smooth muscle cell proliferation and survival through ubiquitin-mediated degradation of FoxO1
F Li, P Xie, Y Fan, H Zhang, L Zheng, D Gu, C Patterson, H Li
The Journal of biological chemistry 2009
CHIP Represses Myocardin-Induced Smooth Muscle Cell Differentiation via Ubiquitin-Mediated Proteasomal Degradation
P Xie, Y Fan, H Zhang, Y Zhang, M She, D Gu, C Patterson, H Li
Molecular and cellular biology 2009
Ubiquitin Ligase Cbl-b Is a Negative Regulator for Insulin-Like Growth Factor 1 Signaling during Muscle Atrophy Caused by Unloading
R Nakao, K Hirasaka, J Goto, K Ishidoh, C Yamada, A Ohno, Y Okumura, I Nonaka, K Yasutomo, KM Baldwin, E Kominami, A Higashibata, K Nagano, K Tanaka, N Yasui, EM Mills, S Takeda, T Nikawa
Molecular and cellular biology 2009
Activation of the Ubiquitin Proteasome System in Doxorubicin Cardiomyopathy
Ranek MJ, Wang X
Current Hypertension Reports 2009
Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation
C Donaldson, S Eder, C Baker, MJ Aronovitz, AD Weiss, M Hall-Porter, F Wang, A Ackerman, RH Karas, JD Molkentin, RD Patten
Circulation research 2008
Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease
MS Willis, JC Schisler, C Patterson
Future Cardiology 2008
Build it up-Tear it down: protein quality control in the cardiac sarcomere
MS Willis, JC Schisler, AL Portbury, C Patterson
Cardiovascular Research 2008
Forkhead transcription factors and cardiovascular biology
KN Papanicolaou, Y Izumiya, K Walsh
Circulation research 2008
The ubiquitin system, disease, and drug discovery
MD Petroski
BMC Biochemistry 2008
Phosphodiesterase 5 inhibition blocks pressure overload-induced cardiac hypertrophy independent of the calcineurin pathway
S Hsu, T Nagayama, N Koitabashi, M Zhang, L Zhou, D Bedja, KL Gabrielson, JD Molkentin, DA Kass, E Takimoto
Cardiovascular Research 2008
Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures
A Chopard, S Hillock, BJ Jasmin
Journal of Cellular and Molecular Medicine 2008
Protein quality control and degradation in cardiomyocytes
X Wang, H Su, MJ Ranek
Journal of Molecular and Cellular Cardiology 2008
Gene expression during inactivity-induced muscle atrophy: effects of brief bouts of a forceful contraction countermeasure
SJ Kim, RR Roy, JA Kim, H Zhong, F Haddad, KM Baldwin, VR Edgerton
Journal of applied physiology 2008
Autophagy in load-induced heart disease
BA Rothermel, JA Hill
Circulation research 2008
Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes
S Sonnberg, BT Seet, T Pawson, SB Fleming, AA Mercer
Proceedings of the National Academy of Sciences 2008
The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy
J Lagirand-Cantaloube, N Offner, A Csibi, MP Leibovitch, S Batonnet-Pichon, LA Tintignac, CT Segura, SA Leibovitch
The EMBO Journal 2008
Acute alcohol intoxication increases atrogin-1 and MuRF1 mRNA without increasing proteolysis in skeletal muscle
TC Vary, RA Frost, CH Lang
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology 2008
PRDM6 is enriched in vascular precursors during development and inhibits endothelial cell proliferation, survival, and differentiation
Y Wu, JE Ferguson, H Wang, R Kelley, R Ren, H McDonough, J Meeker, PC Charles, H Wang, C Patterson
Journal of Molecular and Cellular Cardiology 2008
Atrogin-1/Muscle atrophy F-box inhibits Akt-dependent cardiac hypertrophy via ubiquitin-dependent co-activation of Forkhead proteins
Hui-Hua Li, Monte S. Willis, Pamela Lockyer, Nathaniel Miller, Holly McDonough, David J. Glass, and Cam Patterson
Journal of Clinical Investigation 2007
The muscle-specific ubiquitin ligase, atrogin-1/MAFbx mediates toxicity from HMG CoA reductase inhibitors
Jun-ichi Hanai, Peirang Cao, Preeti Tanksale, Shintaro Imamura, Eriko Koshimizu, Jinghui Zhang, Shuji Kishi, Michiaki Yamashita1, Paul S. Phillips, Vikas P. Sukhatme and Stewart H. Lecker.
Journal of Clinical Investigation 2007
A naturally occurring calcineurin variant inhibits FoxO activity and enhances skeletal muscle regeneration
E Lara-Pezzi, N Winn, A Paul, K McCullagh, E Slominsky, MP Santini, F Mourkioti, P Sarathchandra, S Fukushima, K Suzuki, N Rosenthal
The Journal of Cell Biology 2007
Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes
T Cardozo, M Pagano
BMC Biochemistry 2007
Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting
D Nury, C Doucet, O Coux
BMC Biochemistry 2007
FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases
YG Ni, N Wang, DJ Cao, N Sachan, DJ Morris, RD Gerard, M Kuro-O, BA Rothermel, JA Hill
Proceedings of the National Academy of Sciences 2007
Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction
J Fielitz, E Rooij, JA Spencer, JM Shelton, S Latif, R der Nagel, S Bezprozvannaya, L Windt, JA Richardson, R Bassel-Duby, EN Olson
Proceedings of the National Academy of Sciences 2007
Alterations in mRNA expression and protein products following spinal cord injury in humans: Alterations in skeletal muscle following spinal cord injury
ML Urso, YW Chen, AG Scrimgeour, PC Lee, KF Lee, PM Clarkson
The Journal of Physiology 2007
Muscle Ring Finger 1, but not Muscle Ring Finger 2, Regulates Cardiac Hypertrophy In Vivo
MS Willis, C Ike, L Li, DZ Wang, DJ Glass, C Patterson
Circulation research 2007
ASB4 Is a Hydroxylation Substrate of FIH and Promotes Vascular Differentiation via an Oxygen-Dependent Mechanism
JE Ferguson, Y Wu, K Smith, P Charles, K Powers, H Wang, C Patterson
Molecular and cellular biology 2007
Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures
M Hoshijima
American journal of physiology. Heart and circulatory physiology 2006
The sarcomeric Z-disc: a nodal point in signalling and disease
D Frank, C Kuhn, HA Katus, N Frey
Journal of Molecular Medicine 2006
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
D Xu, N Li, Y He, V Timofeyev, L Lu, HJ Tsai, IH Kim, D Tuteja, RK Mateo, A Singapuri, BB Davis, R Low, BD Hammock, N Chiamvimonvat
Proceedings of the National Academy of Sciences 2006
Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling
YG Ni, K Berenji, N Wang, M Oh, N Sachan, A Dey, J Cheng, G Lu, DJ Morris, DH Castrillon, RD Gerard, BA Rothermel, JA Hill
Circulation 2006
Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc
J Heineke, H Ruetten, C Willenbockel, SC Gross, M Naguib, A Schaefer, T Kempf, D Hilfiker-Kleiner, P Caroni, T Kraft, RA Kaiser, JD Molkentin, H Drexler, KC Wollert
Proceedings of the National Academy of Sciences 2005
The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling
C Skurk, Y Izumiya, H Maatz, P Razeghi, I Shiojima, M Sandri, K Sato, L Zeng, S Schiekofer, D Pimentel, S Lecker, H Taegtmeyer, AL Goldberg, K Walsh
The Journal of biological chemistry 2005
Phylogenetic origin of LI-cadherin revealed by protein and gene structure analysis.
Jung R, Wendeler MW, Danevad M, Himmelbauer H, Gessner R
Cellular and molecular life sciences : CMLS 2004

← Previous 1 2 3 … 7 8 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts